{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:09:36Z","timestamp":1790946576817,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>This review highlights recent advances in the understanding and management of gastrointestinal manifestations in systemic sclerosis (SSc). It is intended for clinicians and researchers aiming to improve diagnostic accuracy and therapeutic strategies in managing SSc-related gastrointestinal disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Gastrointestinal involvement in SSc is highly variable in terms of clinical presentation, symptom severity, progression, timing of onset, and response to treatment. Emerging research highlights early immune-mediated damage to neural and muscular gastrointestinal tissues, microbiome alterations, and vascular dysfunction \u2013 particularly in patients with late-onset gastrointestinal disease \u2013 as key factors guiding the development of personalized, precision-based approaches for well defined patient subgroups. Recent studies underscore the value of early, objective assessment of gastrointestinal motility using tools like whole-gut transit scintigraphy and abdominal vascular ultrasound. New treatment strategies are also being explored for severe manifestations, including investigating mechanisms behind acid-suppressive therapy-resistant gastroesophageal reflux disease and implementing adjunctive therapies for gastrointestinal dysmotility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Gastrointestinal involvement in SSc poses a complex clinical challenge, particularly in patients with severe dysmotility and symptoms refractory to standard management strategies. This review offers timely, evidence-based insights to support clinicians in delivering more personalized and effective patient care and highlights critical gaps to address in future research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000001110","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T15:08:47Z","timestamp":1752246527000},"page":"365-372","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Gastrointestinal manifestations of systemic sclerosis: current approaches and emerging therapies"],"prefix":"10.1097","volume":"37","author":[{"given":"Luis G.","family":"Alcala-Gonzalez","sequence":"first","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Hinchcliff","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Rheumatology, Allergy & Immunology"},{"name":"Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna H.","family":"McMahan","sequence":"additional","affiliation":[{"name":"UT Health Houston, Department of Medicine, Division of Rheumatology, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"R1-20251007","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41584-023-00929-1","article-title":"Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management","volume":"19","author":"McMahan","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20251007","doi-asserted-by":"crossref","first-page":"101666","DOI":"10.1016\/j.berh.2021.101666","article-title":"A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis","volume":"35","author":"Kaniecki","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R3-20251007","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"R4-20251007","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/BOR.0000000000000899","article-title":"Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment","volume":"34","author":"Volkmann","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"R5-20251007","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/art.1780370902","article-title":"Gastrointestinal motility disorders in scleroderma","volume":"37","author":"Sjogren","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R6-20251007","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls","volume":"46","author":"D\u2019Angelo","year":"1969","journal-title":"Am J Med"},{"key":"R7-20251007","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10067-020-05325-8","article-title":"Intestinal hypomotility in systemic sclerosis: a histological study into the sequence of events","volume":"40","author":"den Braber-Ymker","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R8-20251007","doi-asserted-by":"crossref","first-page":"152268","DOI":"10.1016\/j.semarthrit.2023.152268","article-title":"Autonomic dysfunction in systemic sclerosis: a scoping review","volume":"63","author":"Di Battista","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"R9-20251007","first-page":"63","article-title":"Current insights on chronic intestinal dysmotility: pseudo-obstruction and enteric dysmotility","volume":"116","author":"Alcal\u00e1 Gonz\u00e1lez","year":"2024","journal-title":"Rev Esp Enferm Dig"},{"key":"R10-20251007","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/acr.25411","article-title":"Evaluating the associations among dysautonomia, gastrointestinal transit, and clinical phenotype in patients with systemic sclerosis","volume":"76","author":"Alvarez-Hernandez","year":"2024","journal-title":"Arthritis Care Res"},{"key":"R11-20251007","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaf197","article-title":"Antimuscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis","author":"Ayla","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"key":"R12-20251007","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.42667","article-title":"Anti-Gephyrin antibodies: a novel specificity in patients with systemic sclerosis and lower bowel dysfunction","volume":"76","author":"McMahan","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"R13-20251007","article-title":"Antimitochondrial antibodies in systemic sclerosis target enteric neurons and are associated with GI dysmotility","author":"McMahan","year":"2024","journal-title":"medRxiv [Preprint]"},{"key":"R14-20251007","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/acr.25118","article-title":"Antivinculin antibodies in systemic sclerosis: associations with slow gastric transit and extraintestinal clinical phenotype","volume":"75","author":"Herr\u00e1n","year":"2023","journal-title":"Arthritis Care Res"},{"key":"R15-20251007","first-page":"334","article-title":"Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"S2665-9913","author":"Fretheim","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"R16-20251007","doi-asserted-by":"crossref","first-page":"e004647","DOI":"10.1136\/rmdopen-2024-004647","article-title":"Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile","volume":"10","author":"Bellando-Randone","year":"2024","journal-title":"RMD Open"},{"key":"R17-20251007","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1093\/rheumatology\/kead486","article-title":"Significant gastrointestinal unmet needs in patients with systemic sclerosis: insights from a large international patient survey","volume":"63","author":"Bandini","year":"2024","journal-title":"Rheumatol Oxf Engl"},{"key":"R18-20251007","doi-asserted-by":"crossref","first-page":"e089725","DOI":"10.1136\/bmjopen-2024-089725","article-title":"Impact of gastrointestinal symptoms and psychological distress on quality of life in systemic sclerosis: a cross-sectional study","volume":"14","author":"Alcala-Gonzalez","year":"2024","journal-title":"BMJ Open"},{"key":"R19-20251007","first-page":"565","article-title":"Scleroderma GI Research Working Group, Annex. Scleroderma GI Research Working Group. Patient perspectives and treatment gaps in managing gastrointestinal symptoms in systemic sclerosis","volume":"S0025-7753","author":"Alcala-Gonzalez","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"R20-20251007","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/acr.25426","article-title":"Prevalence and outcomes of gastrointestinal manifestations in an Australian Scleroderma Cohort","volume":"76","author":"Quinlivan","year":"2024","journal-title":"Arthritis Care Res"},{"key":"R21-20251007","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/rheumatology\/keae691","article-title":"Systemic sclerosis-related fecal incontinence: a scoping review focusing on a neglected manifestation","volume":"64","author":"Lescoat","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"key":"R22-20251007","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1093\/rheumatology\/keae469","article-title":"Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis","volume":"64","author":"Perin","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"key":"R23-20251007","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11739-024-03783-5","article-title":"Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literature","volume":"20","author":"Bandini","year":"2025","journal-title":"Intern Emerg Med"},{"key":"R24-20251007","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10620-023-08151-5","article-title":"Diffuse gastrointestinal motor compromise in patients with scleroderma: utility of minimally invasive techniques","volume":"69","author":"von M\u00fchlenbrock","year":"2024","journal-title":"Dig Dis Sci"},{"key":"R25-20251007","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1093\/rheumatology\/keae481","article-title":"Gastrointestinal dysmotility is associated with proton pump inhibitor refractory esophagitis in patients with systemic sclerosis","volume":"64","author":"Alcala-Gonzalez","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"key":"R26-20251007","doi-asserted-by":"crossref","first-page":"e14058","DOI":"10.1111\/nmo.14058","article-title":"Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0\u00a9","volume":"33","author":"Yadlapati","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"R27-20251007","doi-asserted-by":"crossref","article-title":"Physiological characterization of gastric emptying using high-resolution antropyloroduodenal manometry","author":"Soliman","DOI":"10.1152\/ajpgi.00101.2023"},{"key":"R28-20251007","doi-asserted-by":"crossref","first-page":"e14907","DOI":"10.1111\/nmo.14907","article-title":"High-resolution versus conventional manometry for the diagnosis of small bowel motor dysfunction","volume":"36","author":"Alcala-Gonzalez","year":"2024","journal-title":"Neurogastroenterol Motil"},{"key":"R29-20251007","doi-asserted-by":"crossref","first-page":"e13679","DOI":"10.1111\/nmo.13679","article-title":"The international anorectal physiology working group (IAPWG) recommendations: standardized testing protocol and the London classification for disorders of anorectal function","volume":"32","author":"Carrington","year":"2020","journal-title":"Neurogastroenterol Motil"},{"key":"R30-20251007","doi-asserted-by":"crossref","first-page":"e11796","DOI":"10.1002\/acr2.11796","article-title":"Abnormal esophageal scintigraphy associates with a distinct clinical phenotype in patients with systemic sclerosis","volume":"7","author":"Salas","year":"2025","journal-title":"ACR Open Rheumatol"},{"key":"R31-20251007","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/acr.25080","article-title":"Associations between patterns of esophageal dysmotility and extra-intestinal features in patients with systemic sclerosis","volume":"75","author":"Tucker","year":"2023","journal-title":"Arthritis Care Res"},{"key":"R32-20251007","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1093\/rheumatology\/keae542","article-title":"Demographics and clinical features associated with abnormal small bowel motility in systemic sclerosis","volume":"64","author":"Cheah","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"key":"R33-20251007","doi-asserted-by":"crossref","first-page":"e01632","DOI":"10.14309\/crj.0000000000001632","article-title":"Gastroesophageal intussusception treated with combined transoral incisionless fundoplication in a patient with systemic sclerosis","volume":"12","author":"Memon","year":"2025","journal-title":"ACG Case Rep J"},{"key":"R34-20251007","doi-asserted-by":"crossref","first-page":"e004333","DOI":"10.1136\/rmdopen-2024-004333","article-title":"Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?","volume":"10","author":"Stamm","year":"2024","journal-title":"RMD Open"},{"key":"R35-20251007","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1093\/rheumatology\/kead093","article-title":"Rapid improvement of systemic sclerosis-associated intestinal pseudo-obstruction with intravenous immunoglobulin administration","volume":"62","author":"Matsuda","year":"2023","journal-title":"Rheumatol Oxf Engl"},{"key":"R36-20251007","article-title":"Efficacy assessment of intravenous immunoglobulin for gastrointestinal involvement in systemic sclerosis using UCLA SCTC GIT: case-based review","author":"Neto","year":"2024","journal-title":"J Scleroderma Relat Disord"},{"key":"R37-20251007","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1093\/rheumatology\/keaf064","article-title":"The role of prokinetics in managing gastrointestinal involvement in systemic sclerosis: a systematic literature review","volume":"64","author":"Ezquerra-Dur\u00e1n","year":"2025","journal-title":"Rheumatol Oxf Engl"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:00:35Z","timestamp":1759813235000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001110","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]}}}